Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 752

1.

A spatiotemporal DNA endoploidy map of the Arabidopsis root reveals roles for the endocycle in root development and stress adaptation.

Bhosale R, Boudolf V, Cuevas F, Lu R, Eekhout T, Hu Z, van Isterdael G, Lambert G, Xu F, Nowack MK, Smith RS, Vercauteren I, De Rycke RM, Storme V, Beeckman T, Larkin JC, Kremer A, Höfte H, Galbraith DW, Kumpf RP, Maere S, De Veylder L.

Plant Cell. 2018 Aug 16. pii: tpc.00983.2017. doi: 10.1105/tpc.17.00983. [Epub ahead of print]

PMID:
30115738
2.

The ovary of Fundulus heteroclitus.

Brummett AR, Dumont JN, Larkin JR.

J Morphol. 1982 Jul;173(1):1-16. doi: 10.1002/jmor.1051730102.

PMID:
30103572
3.

Optimization of molecularly targeted MRI in the brain: empirical comparison of sequences and particles.

Zarghami N, Khrapitchev AA, Perez-Balderas F, Soto MS, Larkin JR, Bau L, Sibson NR.

Int J Nanomedicine. 2018 Jul 25;13:4345-4359. doi: 10.2147/IJN.S158071. eCollection 2018.

4.

Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.

Hauschild A, Larkin J, Ribas A, Dréno B, Flaherty KT, Ascierto PA, Lewis KD, McKenna E, Zhu Q, Mun Y, McArthur GA.

JAMA Oncol. 2018 Aug 2. doi: 10.1001/jamaoncol.2018.2668. [Epub ahead of print]

PMID:
30073321
5.

Signal Percolation within a Bacterial Community.

Larkin JW, Zhai X, Kikuchi K, Redford SE, Prindle A, Liu J, Greenfield S, Walczak AM, Garcia-Ojalvo J, Mugler A, Süel GM.

Cell Syst. 2018 Jul 14. pii: S2405-4712(18)30245-X. doi: 10.1016/j.cels.2018.06.005. [Epub ahead of print]

6.

Elusive search for effective provider interventions: a systematic review of provider interventions to increase adherence to evidence-based treatment for depression.

Pedersen ER, Rubenstein L, Kandrack R, Danz M, Belsher B, Motala A, Booth M, Larkin J, Hempel S.

Implement Sci. 2018 Jul 20;13(1):99. doi: 10.1186/s13012-018-0788-8. Review.

7.

Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection.

Flynn M, Pickering L, Larkin J, Turajlic S.

Ther Adv Med Oncol. 2018 Jun 12;10:1758835918777427. doi: 10.1177/1758835918777427. eCollection 2018. Review.

8.

Brave new world.

Larkin J.

Scott Med J. 2018 Feb;63(1):1-2. doi: 10.1177/0036933018784173. No abstract available.

PMID:
29956603
9.

Doctors, negligence and the GMC.

Larkin J.

Scott Med J. 2018 May;63(2):35-37. doi: 10.1177/0036933018784174. Epub 2018 Jun 26. No abstract available.

PMID:
29945492
10.

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy.

Higham CE, Olsson-Brown A, Carroll P, Cooksley T, Larkin J, Lorigan P, Morganstein D, Trainer PJ; Society for Endocrinology Clinical Committee.

Endocr Connect. 2018 Jul;7(7):G1-G7. doi: 10.1530/EC-18-0068.

11.

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Haanen JBAG, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K; ESMO Guidelines Committee.

Ann Oncol. 2018 Jun 15. doi: 10.1093/annonc/mdy162. [Epub ahead of print] No abstract available.

PMID:
29917046
12.

Association of Smoking Status With Mortality and Hospitalization in Hemodialysis Patients.

Li NC, Thadhani RI, Reviriego-Mendoza M, Larkin JW, Maddux FW, Ofsthun NJ.

Am J Kidney Dis. 2018 Jun 14. pii: S0272-6386(18)30641-3. doi: 10.1053/j.ajkd.2018.04.004. [Epub ahead of print]

PMID:
29909936
13.

Functional Analysis of Short Linear Motifs in the Plant Cyclin-Dependent Kinase Inhibitor SIAMESE.

Kumar N, Dale R, Kemboi D, Zeringue EA, Kato N, Larkin JC.

Plant Physiol. 2018 Aug;177(4):1569-1579. doi: 10.1104/pp.18.00147. Epub 2018 Jun 14.

14.

Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54].

Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HBA, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP.

Eur Urol. 2018 May 28. pii: S0302-2838(18)30366-X. doi: 10.1016/j.eururo.2018.05.017. [Epub ahead of print] No abstract available.

PMID:
29853305
15.

Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis.

Sun M, Marconi L, Eisen T, Escudier B, Giles RH, Haas NB, Harshman LC, Quinn DI, Larkin J, Pal SK, Powles T, Ryan CW, Sternberg CN, Uzzo R, Choueiri TK, Bex A.

Eur Urol. 2018 May 18. pii: S0302-2838(18)30349-X. doi: 10.1016/j.eururo.2018.05.002. [Epub ahead of print] Review.

PMID:
29784193
16.

Making Epidermal Bladder Cells Bigger: Developmental- and Salinity-Induced Endopolyploidy in a Model Halophyte.

Barkla BJ, Rhodes T, Tran KT, Wijesinghege C, Larkin JC, Dassanayake M.

Plant Physiol. 2018 Jun;177(2):615-632. doi: 10.1104/pp.18.00033. Epub 2018 May 3.

17.

Modal analysis of the thermal conductivity of nanowires: examining unique thermal transport features.

Samaraweera N, Larkin JM, Chan KL, Mithraratne K.

J Phys Condens Matter. 2018 Jun 6;30(22):225301. doi: 10.1088/1361-648X/aabe54. Epub 2018 Apr 16.

PMID:
29658884
18.

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Lichinitser M, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Maio M, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan P, Ibrahim N, Marreaud S, van Akkooi ACJ, Suciu S, Robert C.

N Engl J Med. 2018 May 10;378(19):1789-1801. doi: 10.1056/NEJMoa1802357. Epub 2018 Apr 15.

PMID:
29658430
19.

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.

Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI, Nicol D, O'Brien T, Larkin J, Horswell S, Stares M, Au L, Jamal-Hanjani M, Challacombe B, Chandra A, Hazell S, Eichler-Jonsson C, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Jabbar F, Spain L, Lall S, Guarch R, Falzon M, Proctor I, Pickering L, Gore M, Watkins TBK, Ward S, Stewart A, DiNatale R, Becerra MF, Reznik E, Hsieh JJ, Richmond TA, Mayhew GF, Hill SM, McNally CD, Jones C, Rosenbaum H, Stanislaw S, Burgess DL, Alexander NR, Swanton C; PEACE; TRACERx Renal Consortium.

Cell. 2018 Apr 19;173(3):581-594.e12. doi: 10.1016/j.cell.2018.03.057. Epub 2018 Apr 12.

20.

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.

Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, O'Brien T, Lopez JI, Watkins TBK, Nicol D, Stares M, Challacombe B, Hazell S, Chandra A, Mitchell TJ, Au L, Eichler-Jonsson C, Jabbar F, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Stewart A, Xing W, Smith JC, Escudero M, Huffman A, Matthews N, Elgar G, Phillimore B, Costa M, Begum S, Ward S, Salm M, Boeing S, Fisher R, Spain L, Navas C, Grönroos E, Hobor S, Sharma S, Aurangzeb I, Lall S, Polson A, Varia M, Horsfield C, Fotiadis N, Pickering L, Schwarz RF, Silva B, Herrero J, Luscombe NM, Jamal-Hanjani M, Rosenthal R, Birkbak NJ, Wilson GA, Pipek O, Ribli D, Krzystanek M, Csabai I, Szallasi Z, Gore M, McGranahan N, Van Loo P, Campbell P, Larkin J, Swanton C; TRACERx Renal Consortium.

Cell. 2018 Apr 19;173(3):595-610.e11. doi: 10.1016/j.cell.2018.03.043. Epub 2018 Apr 12.

21.

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.

Mitchell TJ, Turajlic S, Rowan A, Nicol D, Farmery JHR, O'Brien T, Martincorena I, Tarpey P, Angelopoulos N, Yates LR, Butler AP, Raine K, Stewart GD, Challacombe B, Fernando A, Lopez JI, Hazell S, Chandra A, Chowdhury S, Rudman S, Soultati A, Stamp G, Fotiadis N, Pickering L, Au L, Spain L, Lynch J, Stares M, Teague J, Maura F, Wedge DC, Horswell S, Chambers T, Litchfield K, Xu H, Stewart A, Elaidi R, Oudard S, McGranahan N, Csabai I, Gore M, Futreal PA, Larkin J, Lynch AG, Szallasi Z, Swanton C, Campbell PJ; TRACERx Renal Consortium.

Cell. 2018 Apr 19;173(3):611-623.e17. doi: 10.1016/j.cell.2018.02.020. Epub 2018 Apr 12.

22.

Are Digitally Delivered Psychological Interventions for Depression the Way Forward? A Review.

Stefanopoulou E, Lewis D, Taylor M, Broscombe J, Ahmad J, Larkin J.

Psychiatr Q. 2018 Apr 14. doi: 10.1007/s11126-018-9576-5. [Epub ahead of print] Review.

PMID:
29656348
23.

A Tale of Two Cycles.

Wang K, Larkin JC.

Dev Cell. 2018 Apr 9;45(1):8-9. doi: 10.1016/j.devcel.2018.03.016.

PMID:
29634938
24.

Effects of biological monitoring and results outreach on private landowner conservation management.

Lutter SH, Dayer AA, Heggenstaller E, Larkin JL.

PLoS One. 2018 Apr 4;13(4):e0194740. doi: 10.1371/journal.pone.0194740. eCollection 2018.

25.

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.

Arce Vargas F, Furness AJS, Litchfield K, Joshi K, Rosenthal R, Ghorani E, Solomon I, Lesko MH, Ruef N, Roddie C, Henry JY, Spain L, Ben Aissa A, Georgiou A, Wong YNS, Smith M, Strauss D, Hayes A, Nicol D, O'Brien T, Mårtensson L, Ljungars A, Teige I, Frendéus B; TRACERx Melanoma; TRACERx Renal; TRACERx Lung consortia, Pule M, Marafioti T, Gore M, Larkin J, Turajlic S, Swanton C, Peggs KS, Quezada SA.

Cancer Cell. 2018 Apr 9;33(4):649-663.e4. doi: 10.1016/j.ccell.2018.02.010. Epub 2018 Mar 22.

26.

Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124].

Valpione S, Carlino MS, Mangana J, Mooradian MJ, McArthur G, Schadendorf D, Hauschild A, Menzies AM, Arance A, Ascierto PA, Giacomo AD, de Rosa F, Larkin J, Park JJ, Goldinger SM, Sullivan RJ, Xu W, Livingstone E, Weichenthal M, Rai R, Gaba L, Long GV, Lorigan P.

Eur J Cancer. 2018 Apr;93:158. doi: 10.1016/j.ejca.2018.02.001. Epub 2018 Mar 13. No abstract available.

PMID:
29548533
27.

Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma.

Lim KHJ, Spain L, Barker C, Georgiou A, Walls G, Gore M, Turajlic S, Board R, Larkin JM, Lorigan P.

ESMO Open. 2018 Feb 24;3(2):e000317. doi: 10.1136/esmoopen-2017-000317. eCollection 2018.

28.

Impact of issuing longer- versus shorter-duration prescriptions: a systematic review.

King S, Miani C, Exley J, Larkin J, Kirtley A, Payne RA.

Br J Gen Pract. 2018 Apr;68(669):e286-e292. doi: 10.3399/bjgp18X695501. Epub 2018 Mar 12.

PMID:
29530921
29.

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.

Choueiri TK, Larkin J, Oya M, Thistlethwaite F, Martignoni M, Nathan P, Powles T, McDermott D, Robbins PB, Chism DD, Cho D, Atkins MB, Gordon MS, Gupta S, Uemura H, Tomita Y, Compagnoni A, Fowst C, di Pietro A, Rini BI.

Lancet Oncol. 2018 Apr;19(4):451-460. doi: 10.1016/S1470-2045(18)30107-4. Epub 2018 Mar 9.

PMID:
29530667
30.

Quantitative blood flow measurement in rat brain with multiphase arterial spin labelling magnetic resonance imaging.

Larkin JR, Simard MA, Khrapitchev AA, Meakin JA, Okell TW, Craig M, Ray KJ, Jezzard P, Chappell MA, Sibson NR.

J Cereb Blood Flow Metab. 2018 Mar 2:271678X18756218. doi: 10.1177/0271678X18756218. [Epub ahead of print]

PMID:
29498562
31.

Relationships between Neighborhood Walkability and Objectively Measured Physical Activity Levels in Hemodialysis Patients.

Han M, Ye X, Preciado P, Williams S, Campos I, Bonner M, Young C, Marsh D, Larkin JW, Usvyat LA, Maddux FW, Pecoits-Filho R, Kotanko P.

Blood Purif. 2018;45(1-3):236-244. doi: 10.1159/000485161. Epub 2018 Jan 26.

32.

BMI and outcomes in melanoma: more evidence for the obesity paradox.

Hayes AJ, Larkin J.

Lancet Oncol. 2018 Mar;19(3):269-270. doi: 10.1016/S1470-2045(18)30077-9. Epub 2018 Feb 12. No abstract available.

PMID:
29449191
33.

Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation-positive melanoma.

Dréno B, Ascierto PA, Atkinson V, Liszkay G, Maio M, Mandalà M, Demidov L, Stroyakovskiy D, Thomas L, de la Cruz-Merino L, Dutriaux C, Garbe C, Bartley K, Karagiannis T, Chang I, Rooney I, Koralek DO, Larkin J, McArthur GA, Ribas A.

Br J Cancer. 2018 Mar 20;118(6):777-784. doi: 10.1038/bjc.2017.488. Epub 2018 Feb 13.

34.

Depressive affect in incident hemodialysis patients.

McDougall KA, Larkin JW, Wingard RL, Jiao Y, Rosen S, Ma L, Usvyat LA, Maddux FW.

Clin Kidney J. 2018 Feb;11(1):123-129. doi: 10.1093/ckj/sfx054. Epub 2017 Jul 11.

35.

Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial.

Yip K, Melcher A, Harrington K, Illidge T, Nobes J, Webster A, Smith D, Lorigan P, Nathan P, Larkin J.

Clin Oncol (R Coll Radiol). 2018 Apr;30(4):201-203. doi: 10.1016/j.clon.2018.01.001. No abstract available.

PMID:
29402599
36.

Feather mite abundance varies but symbiotic nature of mite-host relationship does not differ between two ecologically dissimilar warblers.

Matthews AE, Larkin JL, Raybuck DW, Slevin MC, Stoleson SH, Boves TJ.

Ecol Evol. 2017 Dec 20;8(2):1227-1238. doi: 10.1002/ece3.3738. eCollection 2018 Jan.

37.

Monosubstituted Phenylboronic Acids, R-B(OH)2 (R = C6H5, C6H4CH3, C6H4NH2, C6H4OH, and C6H4F): A Computational Investigation.

Rao NZ, Larkin JD, Bock CW.

Struct Chem. 2017 Aug;28(4):945-955. doi: 10.1007/s11224-016-0897-4. Epub 2016 Dec 15.

38.

First report of overall survival for ipilimumab plus nivolumab from the phase III Checkmate 067 study in advanced melanoma.

Turajlic S, Gore M, Larkin J.

Ann Oncol. 2018 Mar 1;29(3):542-543. doi: 10.1093/annonc/mdy020. No abstract available.

PMID:
29360923
39.

Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study.

Valpione S, Carlino MS, Mangana J, Mooradian MJ, McArthur G, Schadendorf D, Hauschild A, Menzies AM, Arance A, Ascierto PA, Di Giacomo A, de Rosa F, Larkin J, Park JJ, Goldinger SM, Sullivan RJ, Xu W, Livingstone E, Weichenthal M, Rai R, Gaba L, Long GV, Lorigan P.

Eur J Cancer. 2018 Mar;91:116-124. doi: 10.1016/j.ejca.2017.12.007. Epub 2018 Jan 19. Erratum in: Eur J Cancer. 2018 Mar 13;:.

40.

Proliferative myositis of the latissimus dorsi presenting in a 20-year-old male athlete.

McHugh N, Tevlin R, Beggan C, Ryan DJ, Larkin J, Moloney F, Bennett MW, Kelly J.

Ir Med J. 2017 Aug 8;110(7):605.

PMID:
29341517
41.

Body Mapping as a Youth Sexual Health Intervention and Data Collection Tool.

Lys C, Gesink D, Strike C, Larkin J.

Qual Health Res. 2018 Jun;28(7):1185-1198. doi: 10.1177/1049732317750862. Epub 2018 Jan 5.

42.

Nivolumab and Ipilimumab in Advanced Melanoma.

Wolchok JD, Rollin L, Larkin J.

N Engl J Med. 2017 Dec 21;377(25):2503-2504. doi: 10.1056/NEJMc1714339. No abstract available.

43.

Effect of Population-Specific Birthweight Curves on Disparities in Perinatal Mortality in Small-for-Gestational Age Pregnancies.

Larkin JC, Naimi AI.

Am J Perinatol. 2018 Jun;35(7):695-702. doi: 10.1055/s-0037-1608791. Epub 2017 Dec 13.

PMID:
29237187
44.

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III.

Grob JJ, Schadendorf D, Lorigan P, Ascierto P, Larkin J, Nathan P, Robert C, Hauschild A, Weber J, Daud A, Hamid O, Dummer R, Hansson J, Hoeller C, Schachter J, Van Akkooi ACJ, Garbe C.

Eur J Cancer. 2018 Mar;91:168-170. doi: 10.1016/j.ejca.2017.11.023. Epub 2017 Dec 7. No abstract available.

PMID:
29224903
45.

Machine Learning for Fetal Growth Prediction.

Naimi AI, Platt RW, Larkin JC.

Epidemiology. 2018 Mar;29(2):290-298. doi: 10.1097/EDE.0000000000000788.

PMID:
29199998
46.

Anti-inflammatory Microglia/Macrophages As a Potential Therapeutic Target in Brain Metastasis.

Andreou KE, Soto MS, Allen D, Economopoulos V, de Bernardi A, Larkin JR, Sibson NR.

Front Oncol. 2017 Oct 30;7:251. doi: 10.3389/fonc.2017.00251. eCollection 2017.

47.

Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib.

Wongchenko MJ, Ribas A, Dréno B, Ascierto PA, McArthur GA, Gallo JD, Rooney IA, Hsu J, Koeppen H, Yan Y, Larkin J.

Pigment Cell Melanoma Res. 2018 Jul;31(4):516-522. doi: 10.1111/pcmr.12670. Epub 2017 Dec 10.

PMID:
29156488
48.

Mechanical Shielding of Rapidly Growing Cells Buffers Growth Heterogeneity and Contributes to Organ Shape Reproducibility.

Hervieux N, Tsugawa S, Fruleux A, Dumond M, Routier-Kierzkowska AL, Komatsuzaki T, Boudaoud A, Larkin JC, Smith RS, Li CB, Hamant O.

Curr Biol. 2017 Nov 20;27(22):3468-3479.e4. doi: 10.1016/j.cub.2017.10.033. Epub 2017 Nov 9.

PMID:
29129534
49.

What's in a name? The orchestrated erosion of doctor-power in the NHS.

Larkin J.

Scott Med J. 2017 Nov;62(4):127-128. doi: 10.1177/0036933017743429. Epub 2017 Nov 10. No abstract available.

PMID:
29126377
50.

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.

Chapman PB, Robert C, Larkin J, Haanen JB, Ribas A, Hogg D, Hamid O, Ascierto PA, Testori A, Lorigan PC, Dummer R, Sosman JA, Flaherty KT, Chang I, Coleman S, Caro I, Hauschild A, McArthur GA.

Ann Oncol. 2017 Oct 1;28(10):2581-2587. doi: 10.1093/annonc/mdx339.

Supplemental Content

Loading ...
Support Center